Becton Dickinson & Co. has recalled 5,059 BD Phoenix M50 and BD Phoenix 100 diagnostic instruments because they may misidentify Escherichia coli (E. coli) in clinical samples. These instruments are used by healthcare facilities to identify bacteria and determine which antibiotics will be effective against an infection. The defect involves specific software versions and could lead to patients receiving an incorrect diagnosis or improper medical treatment for E. coli infections. This recall affects 4,295 BD Phoenix M50 units and 764 BD Phoenix 100 units distributed worldwide.
If the instrument incorrectly identifies E. coli, a patient might be diagnosed with the wrong type of infection or given an antibiotic that is not effective against their actual illness. This can delay proper treatment and lead to more severe health complications from the underlying E. coli infection.
Manufacturer Notification and Software Update
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.